Mechanistic insights into influenza vaccine-associated narcolepsy

References

• Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015; 7:294ra105; PMID:26136476
   PubMed Web of Science ®Google Scholar
• Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015; 47:44-57; PMID:25452148
   PubMed Web of Science ®Google Scholar
• Vaarala O, Vuorela A, Partinen M, Baumann M, Freitag TL, Meri S, Saavalainen P, Jauhiainen M, Soliymani R, Kirjavainen T, et al. Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk. PLoS One 2014; 9:e114361; PMID:25501681; http://dx.doi.org/10.1371/journal.pone.0114361
   PubMed Web of Science ®Google Scholar
• van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics 2015; 67:1-6; PMID:25277311; http://dx.doi.org/10.1007/s00251-014-0808-z
   PubMed Web of Science ®Google Scholar
• de LL, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95:322-7; PMID:9419374; http://dx.doi.org/10.1073/pnas.95.1.322
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-85; PMID:9491897; http://dx.doi.org/10.1016/S0092-8674(00)80949-6
   PubMed Web of Science ®Google Scholar
• Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39-40; PMID:10615891; http://dx.doi.org/10.1016/S0140-6736(99)05582-8
   PubMed Web of Science ®Google Scholar
• Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-7; PMID:10973318; http://dx.doi.org/10.1038/79690
   PubMed Web of Science ®Google Scholar
• Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98:365-76; PMID:10458611; http://dx.doi.org/10.1016/S0092-8674(00)81965-0
   PubMed Web of Science ®Google Scholar
• Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003; 38:715-30; PMID:12797957; http://dx.doi.org/10.1016/S0896-6273(03)00330-1
   PubMed Web of Science ®Google Scholar
• Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98:437-51; PMID:10481909; http://dx.doi.org/10.1016/S0092-8674(00)81973-X
   PubMed Web of Science ®Google Scholar
• Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001; 30:345-54; PMID:11394998; http://dx.doi.org/10.1016/S0896-6273(01)00293-8
   PubMed Web of Science ®Google Scholar
• Thompson MD, Comings DE, Abu-Ghazalah R, Jereseh Y, Lin L, Wade J, Sakurai T, Tokita S, Yoshida T, Tanaka H, et al. Variants of the orexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am J Med Genet B Neuropsychiatr Genet 2004; 129B:69-75; PMID:15274044; http://dx.doi.org/10.1002/ajmg.b.30047
   PubMed Web of Science ®Google Scholar
• EudraVigilance management system (DBMS). European Medicines Agency, 2015
   Google Scholar
• Johansen K. The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol 2014; 56:1041-2; PMID:25052448; http://dx.doi.org/10.1111/dmcn.12543
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014; 50:1-11; PMID:24559657; http://dx.doi.org/10.1016/j.jaut.2014.01.033
   PubMed Web of Science ®Google Scholar
• Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014; 56:1117-23; PMID:25041214; http://dx.doi.org/10.1111/dmcn.12522
   PubMed Web of Science ®Google Scholar
• Stowe J, Miller E, Andrews N, Kosky C, Leschziner G, Shneerson JM, Hall A, Eriksson S, Reading P, Dennis G, et al. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep 2016; [Epub ahead of print] PMID:26856903
   PubMed Web of Science ®Google Scholar
• Tsai TF. MF59 adjuvanted seasonal and pandemic influenza vaccines. Yakugaku Zasshi 2011; 131:1733-41; PMID:22129867; http://dx.doi.org/10.1248/yakushi.131.1733
   PubMed Web of Science ®Google Scholar
• European Center for Disease P, Control. Enhanced Monitoring of Vaccine Safety for 2009 Pandemic Vaccines. 2013.
   Google Scholar
• Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De WP. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014; 9:e108489; PMID:25264897; http://dx.doi.org/10.1371/journal.pone.0108489
   PubMed Web of Science ®Google Scholar
• Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 2001; 11:531-9; PMID:11282968; http://dx.doi.org/10.1101/gr.GR-1610R
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Plotkin SA, Black S, Coffman RL. Assessing the safety of adjuvanted vaccines. Sci Transl Med 2011; 3:93rv2; PMID:21795590
   PubMed Web of Science ®Google Scholar
• Hampe CS. B Cell in Autoimmune Diseases. Scientifica (Cairo) 2012; 2012:1-18; http://dx.doi.org/10.6064/2012/215308
   Google Scholar
• Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006; 7:153; PMID:16545123; http://dx.doi.org/10.1186/1471-2105-7-153
   PubMed Web of Science ®Google Scholar
• Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep 2006; 29:633-8; PMID:16774153
   PubMed Web of Science ®Google Scholar
• Robertson N, Jazayeri A, Errey J, Baig A, Hurrell E, Zhukov A, Langmead CJ, Weir M, Marshall FH. The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 2011; 60:36-44; PMID:20624408; http://dx.doi.org/10.1016/j.neuropharm.2010.07.001
   PubMed Web of Science ®Google Scholar
• de Hoog HP, Lin JieRong EM, Banerjee S, Decaillot FM, Nallani M. Conformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranes. PLoS One 2014; 9:e110847; PMID:25329156; http://dx.doi.org/10.1371/journal.pone.0110847
   PubMedGoogle Scholar
• Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK. Adrenaline-activated structure of beta2-adrenoceptor stabilized by an engineered nanobody. Nature 2013; 502:575-9; PMID:24056936; http://dx.doi.org/10.1038/nature12572
   PubMed Web of Science ®Google Scholar
• Hislop JN, von Zastrow M. Analysis of GPCR localization and trafficking. Methods Mol Biol 2011; 746:425-40; PMID:21607873; http://dx.doi.org/10.1007/978-1-61779-126-0_25
   PubMedGoogle Scholar
• Vincent A, Waters P, Leite MI, Jacobson L, Koneczny I, Cossins J, Beeson D. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann NY Acad Sci 2012; 1274:92-8; PMID:23252902; http://dx.doi.org/10.1111/j.1749-6632.2012.06789.x
   PubMed Web of Science ®Google Scholar
• Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 2014; 37:1601-8; PMID:25197808
   PubMed Web of Science ®Google Scholar
• Drakatos P, Leschziner G. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin - an Explanation? J Clin Sleep Med 2015; 12(3):449-50
   Web of Science ®Google Scholar
• Tesoriero C, Codita A, Zhang MD, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljestrom P, et al. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 2016; 113:E368-77; PMID:26668381; http://dx.doi.org/10.1073/pnas.1521463112
   PubMed Web of Science ®Google Scholar
• Brask J, Chauhan A, Hill RH, Ljunggren HG, Kristensson K. Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins. J Neurovirol 2005; 11:395-402; PMID:16162482; http://dx.doi.org/10.1080/13550280500186916
   PubMed Web of Science ®Google Scholar
• Thannickal TC, Siegel JM, Nienhuis R, Moore RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 2003; 13:340-51; PMID:12946023; http://dx.doi.org/10.1111/j.1750-3639.2003.tb00033.x
   PubMed Web of Science ®Google Scholar
• Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-74; PMID:11055430; http://dx.doi.org/10.1016/S0896-6273(00)00058-1
   PubMed Web of Science ®Google Scholar
• Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J Neurosci 2011; 31:6305-10; PMID:21525270; http://dx.doi.org/10.1523/JNEUROSCI.0365-11.2011
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci 2010; 30:12642-52; PMID:20861370; http://dx.doi.org/10.1523/JNEUROSCI.2120-10.2010
   PubMed Web of Science ®Google Scholar
• Valko PO, Gavrilov YV, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE. Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol 2013; 74:794-804; PMID:24006291; http://dx.doi.org/10.1002/ana.24019
   PubMed Web of Science ®Google Scholar